
About the Symposium
The 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics will be held in person at the CCIB in Barcelona in November 2026.
Recognised as a leading forum for drug development and translational research, ENA 2026 will spotlight cutting-edge preclinical and phase I studies, fostering deep scientific exchange around emerging targets and novel therapeutics.
Bringing together a global community of researchers, clinicians, and industry experts, the Symposium offers a dynamic platform to explore the latest breakthroughs in molecular biology, target identification, and drug innovation.
Latest news
MYC inhibitor drug targets cancer cells directly and via the immune system
‘Pan-RAS molecular glue’ is a safe and effective treatment for lung and pancreatic cancers: results from AURORAS-1 clinical trial
Metastatic pancreatic cancer responds well to initial treatment with combination of daraxonrasib and chemotherapy
Antibody-drug conjugate shows promising early results in phase I trial in sarcoma patients
New drug IACS-6274 shows promise in phase I clinical trial treating patients with advanced ovarian cancer
Antibody-drug conjugate designed to target tumour ‘scaffolding’ produces positive results
Relive the highlights
of ENA 2026
Discover the moments, people and highlights of this year’s symposium.
Reasons to Participate
Discover why ENA 2026 is the premier event for cancer research and drug development
Leading the way
Driving the discussion on cancer drug development
Ground-breaking data
Scientific evidence powering the latest progress
Networking
Expand your global network
Influencing research
Influence the future of clinical cancer research
Programme
Plan your sessions by viewing the latest searchable programme
Searchable Programme
View the latest searchable programme to plan your sessions and view abstracts.
Key Dates
1 April
Abstract submission opens29 May
Early rate registration26 June
Abstract submission closes4 September
Regular rate registration closes
Meet the Chairs
Featuring 60+ global expert speakers shaping drug development and translational research

Chair, ENA 2026
Elena Garralda

Co-Chair [AACR]
Ryan Corcoran

Co-Chair [NCI]
Tim Greten



